ResMed | RMD - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Ansell USD 1.97B 10.2M 2025-12
Artivion USD 448.23M 9.54M 2025-12
AtriCure USD 491.69M 242K 2026-03
Baxter International USD 6.04B 86M 2026-03
Cochlear AUD 1.94B 12.2M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
CSL USD 18.66B 2.75B 2025-12
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.34B 132.6M 2025-12
Fisher Paykel Healthcare NZD 1.99B 95.8M 2025-12
Globus Medical USD 4.57B 174.42M 2025-12
Haemonetics USD 911.45M 62.28M 2025-12
Idexx Laboratories USD 1.56B 49.28M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Philips EUR 10.58B 204M 2025-09
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.49B 171.03M 2026-03
Sigma Healthcare AUD 4.67B 3.8B 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Steris USD 7.15B 145.4M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03